Geode Capital Management, LLC Cyclerion Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.12 Trillion
Q2 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.43 - $0.9 $2,365 - $4,950	5,500 Added 0.94%	592,237 $254,000
Q4 2022 Feb 13, 2023	BUY	$0.42 - $18.8 $1,225 - $54,858	2,918 Added 0.5%	586,737 $385,000
Q3 2022 Nov 14, 2022	BUY	$0.58 - $18.2 $5,872 - $184,275	10,125 Added 1.76%	583,819 $502,000
Q2 2022 Aug 12, 2022	SELL	$0.47 - $1.29 $4,553 - $12,498	-9,689 Reduced 1.66%	573,694 $314,000
Q1 2022 May 13, 2022	BUY	$0.96 - $1.78 $16,846 - $31,235	17,548 Added 3.1%	583,383 $647,000
Q4 2021 Feb 11, 2022	BUY	$1.56 - $2.99 $117,273 - $224,773	75,175 Added 15.32%	565,835 $973,000
Q3 2021 Nov 12, 2021	BUY	$2.73 - $4.13 $288,943 - $437,119	105,840 Added 27.5%	490,660 $1.51 Million
Q2 2021 Aug 13, 2021	SELL	$2.18 - $4.29 $222,663 - $438,176	-102,139 Reduced 20.97%	384,820 $1.5 Million
Q1 2021 May 12, 2021	BUY	$2.69 - $5.12 $142,830 - $271,856	53,097 Added 12.24%	486,959 $1.36 Million
Q4 2020 Feb 12, 2021	BUY	$2.25 - $7.12 $182,004 - $575,943	80,891 Added 22.92%	433,862 $1.33 Million
Q3 2020 Nov 13, 2020	BUY	$3.46 - $8.39 $127,390 - $308,903	36,818 Added 11.65%	352,971 $2.15 Million
Q2 2020 Aug 13, 2020	SELL	$2.37 - $7.14 $16,232 - $48,901	-6,849 Reduced 2.12%	316,153 $1.87 Million
Q1 2020 May 14, 2020	BUY	$2.46 - $5.84 $55,667 - $132,153	22,629 Added 7.53%	323,002 $855,000
Q4 2019 Feb 13, 2020	BUY	$1.8 - $13.43 $98,100 - $731,935	54,500 Added 22.17%	300,373 $817,000
Q3 2019 Nov 12, 2019	BUY	$8.12 - $14.54 $35,947 - $64,368	4,427 Added 1.83%	245,873 $2.98 Million
Q2 2019 Aug 14, 2019	BUY	$9.6 - $22.85 $2.32 Million - $5.52 Million	241,446 New	241,446 $2.76 Million

Others Institutions Holding CYCN

# of Institutions

Shares Held

293K

Call Options Held

Put Options Held

Trustcore Financial Services, LLC

293K
Shares

$766,729
0.02% of portfolio

View Full List

About Cyclerion Therapeutics, Inc.

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $114M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

More about CYCN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account